These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3651739)

  • 1. Electrodermal responding and chlorpromazine treatment in schizophrenia.
    Yannitsi S; Liakos A; Papakostas Y
    Br J Psychiatry; 1987 Jun; 150():850-3. PubMed ID: 3651739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of propranolol and phenothiazines on electrodermal orienting and habituation in schizophrenia.
    Gruzelier J; Connolly J; Eves F; Hirsch S; Zaki S; Weller M; Yorkston N
    Psychol Med; 1981 Feb; 11(1):93-108. PubMed ID: 6111100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of D-or DL-propranolol and chlorpromazine on habituation of phasic electrodermal responses in schizophrenia.
    Gruzelier JH; Hirsch SR; Weller M; Murphy C
    Acta Psychiatr Scand; 1979 Sep; 60(3):241-8. PubMed ID: 495166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empathy in electrodermal responsive and nonresponsive patients with schizophrenia.
    Ikezawa S; Corbera S; Liu J; Wexler BE
    Schizophr Res; 2012 Dec; 142(1-3):71-6. PubMed ID: 23058162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of chlorpromazine and amylobarbitone on the recovery limb of the electrodermal response.
    Kugler BT; Gruzelier JH
    Psychiatry Res; 1980 Mar; 2(1):75-84. PubMed ID: 6932055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrodermal activity in schizophrenia: a quantitative study using a short interstimulus paradigm.
    Lim CL; Gordon E; Harris A; Bahramali H; Li WM; Manor B; Rennie C
    Biol Psychiatry; 1999 Jan; 45(1):127-35. PubMed ID: 9894584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The orienting response in schizophrenia: proposed resolution of a controversy.
    Levinson DF; Edelberg R; Bridger WH
    Biol Psychiatry; 1984 Apr; 19(4):489-507. PubMed ID: 6733171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response time and electrodermal measures in chronic schizophrenia: the effects of chlorpromazine.
    Pugh LA
    J Nerv Ment Dis; 1968 Jan; 146(1):62-70. PubMed ID: 5648860
    [No Abstract]   [Full Text] [Related]  

  • 9. Electrodermal activity and therapeutic response to neuroleptic treatment in chronic schizophrenic in-patients.
    Schneider SJ
    Psychol Med; 1982 Aug; 12(3):607-13. PubMed ID: 7134318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of symptomatology and medication to electrodermal activity in schizophrenia.
    Green MF; Nuechterlein KH; Satz P
    Psychophysiology; 1989 Mar; 26(2):148-57. PubMed ID: 2567035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic effects on electrodermal responsivity to soft tones and loud noise in schizophrenia.
    Green MF; Nuechterlein KH
    Psychiatry Res; 1988 Apr; 24(1):79-86. PubMed ID: 2899332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orienting, habituation, sensitisation, and dishabituation in the electrodermal system of consecutive, drug free, admissions for schizophrenia.
    Gruzelier J; Eves F; Connolly J; Hirsch S
    Biol Psychol; 1981; 12(2-3):187-209. PubMed ID: 7332772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chlorpromazine on sleep quality, clinical and emotional measures among patients with schizophrenia.
    Meng Q; Li R; Hou F; Zhang Q
    Clin Neurol Neurosurg; 2018 Feb; 165():134-138. PubMed ID: 29421173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
    Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S
    Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial.
    Lal S; Thavundayil JX; Nair NP; Annable L; Ng Ying Kin NM; Gabriel A; Schwartz G
    J Psychiatry Neurosci; 2006 Jul; 31(4):271-9. PubMed ID: 16862245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early parental death: relation to electrodermal orienting response and gender in schizophrenia.
    Ohlund LS; Hultman CM
    Schizophr Res; 1992 Jul; 7(2):125-33. PubMed ID: 1515373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neuroleptics on electrodermal activity in schizophrenic patients: a review.
    Schnur DB
    Psychopharmacology (Berl); 1990; 102(4):429-37. PubMed ID: 1982901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral skin conductance, finger pulse volume, and EEG orienting response to tones of differing intensities in chronic schizophrenics and controls.
    Bernstein AS; Taylor KW; Starkey P; Juni S; Lubowsky J; Paley H
    J Nerv Ment Dis; 1981 Aug; 169(8):513-28. PubMed ID: 7264621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chlorpromazine upon psychophysiological, endocrine and information processing measures in schizophrenia.
    Gruzelier JH; Hammond NV
    J Psychiatr Res; 1978; 14(1-4):167-82. PubMed ID: 722623
    [No Abstract]   [Full Text] [Related]  

  • 20. Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls.
    Nilsson BM; Hultman CM; Wiesel FA
    Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):339-46. PubMed ID: 16600583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.